B Type Natriuretic Peptide BNP Test Kit 5-5000pg/ML For Nephrology

B-Type Natriuretic Peptide Detection Reagent(BNP)(Immunofluorescence Chromatography) Clinical Significance

BNP Overview

BNP is mainly synthesized and secreted by ventricular myocytes, and the changes of ventricular load and wall tension are the main conditions to stimulate BNP secretion. BNP can promote the excretion and urination of sodium, has a strong vasodilation effect. B-type natriuretic peptide is significantly increased in patients with atrial fibrillation and heart failure. BNP is one of the most common biomarkers of heart failure in clinical application.

There are two ways to clear BNP: one is mediated by the C-type receptor of the natriuretic peptide family, which is degraded by lysosomes after being endocytosed into the cell; the other is degradation by neutral endopeptidase (NEP).

BNP performance index

BNP Clinical Significance

• Differential diagnosis and risk stratification in patients with early heart failure
• Evaluation of the severity of heart failure.
• Risk stratification of acute coronary heart disease.
• Differentiation of different causes of heart failure and dyspnea
• Drug efficacy monitoring

Application Department

Cardiology, emergency department, Nephrology, respiratory medicine, etc

BNP Clinical comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.